Clinical trial · Observational
Pivotal Influence of Obesity on Body Composition and Ovarian Doppler in Different Polycystic Ovarian Syndrome Phenotypes
The Pivotal Influence of Obesity on Body Composition and Ovarian Doppler in Different Polycystic Ovarian Syndrome Phenotypes: An Observational Study
NCT06164132CI-TRIAL-00074008completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aimed to explore the impact of obesity on both body composition and ovarian Doppler parameters across various phenotypes of females diagnosed with polycystic ovarian syndrome (PCOS). Additionally, the investigation seeked to establish correlations between these parameters and their prevalence concerning the clinical criteria of PCOS.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Obesity | — | UNRESOLVED | — |
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Evaluation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Normal Weight group
- description
- Their BMI ranged from 18.5 to 24.9 kg/m2.
- interventionNames
- Other: Evaluation
- label
- Overweight group
- description
- Their BMI ranged from 25 to 29.9 kg/m2.
- interventionNames
- Other: Evaluation
- label
- Obese group
- description
- Their BMI was ≥ 30 kg/m2.
- interventionNames
- Other: Evaluation
Primary outcomes (10)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Age ranged from 18 to 40 years old. * Individuals with Polycystic Ovary Syndrome (PCOS) should exhibit at least two of the three features outlined in the Rotterdam criteria for diagnosis, encompassing oligo- or anovulation, clinical and/or biochemical indications of hyperandrogenism, and the presence of polycystic ovaries as identified through ultrasonography. Exclusion Criteria: * Congenital adrenal hyperplasia * Thyroid dysfunction * Hyperprolactinemia * Androgen-secreting tumors * Cushing syndrome * Undergoing any medical therapy for the treatment of PCOS or for weight loss.
References
Publications (0)
Data not yet available
No reference posted for this study.